Last reviewed · How we verify

NCT04508504: PENG

PENG Block for Arthroscopic Hip Surgery

Completed NA Last updated 25 March 2022
What this trial tests

NA trial testing Preop PENG block in Postoperative Pain in 70 participants. Completed in 8 February 2022.

Timeline
1 December 2020
Primary endpoint
1 February 2022
8 February 2022

Quick facts

Lead sponsorUniversity of Virginia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment70
Start date1 December 2020
Primary completion1 February 2022
Estimated completion8 February 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Virginia

Who can join

18 and older, any sex, with Postoperative Pain or Hip Arthroscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pericapsular nerve group (PENG) block for hip arthroscopy: a randomized, double-blinded, placebo-controlled trial.
    Amato PE, Coleman JR, Dobrzanski TP, Elmer DA, et al · · 2022 · cited 17× · PMID 35998937 · DOI 10.1136/rapm-2022-103907

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other University of Virginia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04508504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing